GFAP and Alzheimer disease: We also show that plasma GFAP is elevated in aged APP/PS1 mice and in APP/PS1 mice that are deficient in plasma HDL, providing preliminary evidence supporting the use of this assay to study plasma GFAP in rodent models of AD.